Entera Bio Ltd — Cash Flow (NASDAQ:ENTX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 10.42 M9.06 M12.5 M7.31 M6.82 M 7 M Cash from investing activities 86 K17 K102 K17 K3 000 83 K Cash from financing activities 3.92 M25.38 M13 K6.04 M4.48 M 16.75 M Free cash flow 10.42 M9.05 M12.45 M7.29 M6.82 M 6.92 M

Notizie

What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)

Opko Health: rating "Buy" confermato da H.C. Wainwright

Opko Health stock rating reiterated at Buy by H.C. Wainwright

Entera Bio nomina Geno Germano presidente del consiglio di amministrazione

Entera Bio appoints Geno Germano as board chairman

OPKO and Entera expand collaboration to develop oral PTH treatment

Entera Bio pianifica la presentazione alla FDA del farmaco per l’osteoporosi nel Q1 2026

Entera Bio plans FDA submission for osteoporosis drug in Q1 2026

H.C. Wainwright conferma rating Buy su Entera Bio dopo qualifica FDA endpoint BMD

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint

L’analogo orale di PTH di Entera Bio mostra una risposta sostenuta del calcio

Entera Bio’s oral PTH analog shows sustained calcium response